Effects of alendronate combined with calcitriol on bone metabolism in the treatment of postmenopausal osteoporosis patients
10.3969/j.issn.1005-1678.2017.05.114
- VernacularTitle:阿仑膦酸钠联合阿法骨化醇治疗绝经后骨质疏松症患者骨代谢的影响研究
- Author:
Shuqing CHEN
;
Feimin GE
;
Yuhui HUA
- Keywords:
alendronate;
alfacalcidol;
women's menopause;
osteoporosis;
bone metabolism
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(5):338-340
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of alendronate combined with calcitriol on bone metabolism in the treatment of postmenopausal osteoporosis patients.Methods66 postmenopausal osteoporosis patients from Cancer Hospital of Hangzhou were selected and randomly divided into the control group and the study group.33 cases in the control group were treated by compound calcium amino acid chelate.33 cases in the study group were treated by compound calcium amino acid chelate, alendronate and alfacalcidol.All patients were taking the drug for 48 weeks.The bone mineral density (BMD) of lumbar vertebrae between 4 and 1, Bone alkaline phosphatase (BALP) and bone metabolism index of left femur (BMD) Type I collagen C end peptide (CTX), acid phosphatase (TRAP), parathyroid hormone (PTH) and clinical curative effect were compared.ResultsAfter treatment, the clinical effective rate of the study group (93.94%) was higher than that of the control group (72.73%), the difference was statistically significant (P<0.05).Compared with the control group,the level of bone mineral density of lumbar spine was increased from 1 to 4, and the level of TRAP, CTX, PTH and BALP were increased,the difference was statistically significant (P<0.05).There was no difference in adverse effects between the two groups.ConclusionThe combination of the application of sodium hyaluronate and the combination of the method can effectively improve the bone mineral density and bone metabolism in postmenopausal women with osteoporosis, and improve the clinical efficacy.
